Staphylococcus aureus and Clostridium difficile cause distinct pseudomembranous intestinal diseases

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
M Kent FrobergStuart Johnson

Abstract

We report simultaneous infections with Clostridium difficile and methicillin-resistant Staphylococcus aureus (MRSA) in a patient with discrete colonic pseudomembranes typical of C. difficile infection, as well as confluent, loosely adherent pseudomembranes in the small bowel. Identification of MRSA in the small bowel pseudomembrane by polymerase chain reaction supports S. aureus as an enteric pathogen.

References

May 20, 1978·Lancet·H E LarsonS P Borriello
Mar 9, 1978·The New England Journal of Medicine·J G BartlettA B Onderdonk
Oct 1, 1991·Journal of Clinical Microbiology·K MurakamiS Watanabe

❮ Previous
Next ❯

Citations

Aug 9, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D S ActonA van Belkum
Feb 7, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John G Bartlett
Jul 18, 2009·Digestive Diseases and Sciences·Zheng LinEmilia Mia Sordillo
Feb 22, 2016·Trends in Microbiology·Sarah LarcombeDena Lyras
May 28, 2015·Gastroenterology Report·Aditya KalakondaSudhir Dutta
Mar 15, 2015·Disease-a-month : DM·Priya D FarooqErik C von Rosenvinge
Mar 14, 2018·Microorganisms·Pietro SpezialeGiampiero Pietrocola
Apr 1, 2015·Infection and Immunity·Thippeswamy H SannasiddappaSimon R Clarke
May 20, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Lisa M AveryErich Weiss
Nov 26, 2014·International Journal of Surgical Pathology·Simon Byrns, Laura A Canterbury
Sep 4, 2018·Case Reports in Infectious Diseases·Alison B LaneJames V Lawler

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
A-C LundellA Rudin
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
B BjörksténM Mikelsaar
Trends in Microbiology
Siegfried Hapfelmeier, Wolf-Dietrich Hardt
© 2021 Meta ULC. All rights reserved